Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fermentation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel fermentation hydrolysis method for Aminoglucose Hydrochloride. High purity, reduced cost, scalable supply chain solution for pharmaceutical manufacturers.
Patent CN103509726A details microbial synthesis of beta-amyrin. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN1563397A details a novel Stenotrophomonas maltophilia fermentation route for high-purity valienamine and validamine, offering scalable pharmaceutical intermediate production.
Patent CN112391372B reveals a novel glutamate decarboxylase mutant enabling high-yield food-grade GABA fermentation with expanded pH activity and industrial scalability.
Patent CN105002106B details engineered strains for high purity antibiotic production offering significant supply chain and cost advantages for global pharmaceutical manufacturers.
Patent CN105950679A reveals advanced fermentation for D-pantolactone. Enhances enzyme stability and reduces costs for vitamin B5 supply chains globally.
Patent CN1592788A reveals non-GMO bioconversion for alpha-ketobutyrate. Enhances supply chain safety and reduces chemical synthesis costs for flavor manufacturers.
Advanced fermentation and resin purification method for echinocandin FR179642. Ensures high purity and scalable supply for global antifungal drug production.
Patent CN102190691B reveals a fermentation-based purification method for EPIDNR. Achieve over 97 percent purity with scalable resin technology for cost-effective API intermediate manufacturing.
Patent CN118221697A reveals advanced ascomycin purification. Reduces solvent use and cost. Ideal for pharmaceutical intermediates manufacturing supply chain.
Patent CN108559766A reveals novel microbial route for steroid intermediates. Achieve higher purity and yield with scalable fermentation for reliable pharmaceutical supply chains.
Patent CN116926139A reveals a novel enzymatic route for N-acetyl-D-amino acid production, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN102876582B details a novel Metarhizium anisopliae strain for efficient 11α-hydroxylation. This biocatalytic route offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN101760495A details a non-toxic bio-route for steroid 1,2-dehydrogenation using Arthrobacter simplex, ensuring high purity and scalable manufacturing for global supply chains.
Novel fermentation route for synthetic oak moss intermediate reduces complexity and ensures high purity supply for fragrance manufacturing.
Patent CN111116370A reveals a fermentation route for synthetic oak moss. This method ensures high purity and supply stability for fragrance manufacturing.
Patent CN101760496A details a biological dehydrogenation method for steroid intermediates using Arthrobacter simplex, offering a safer, high-yield alternative to toxic chemical processes for reliable supply chains.
Patent CN112899191B reveals a green route from phytosterol to bile acids, offering supply chain stability and cost efficiency for pharmaceutical manufacturers.
Patent CN112342261B reveals a green route for prednisone acetate using RSA. Discover cost-effective biocatalytic hydroxylation and oxidation for high-purity steroid production.
Patent CN109680032B reveals a high-yield microbial route for steroid hydroxylation. Discover cost-effective manufacturing and reliable supply chain solutions for pharmaceutical intermediates.